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Copper signaling in the mammalian nervous system: synaptic
effects
ED Gaier, BA Eipper, and RE Mains
Department of Neuroscience, University of Connecticut Health Center, Farmington, CT 06030
Abstract
Copper (Cu) is an essential metal present at high levels in the CNS. Its role as a co-factor in
mitochondrial ATP production and in other essential cuproenzymes is well defined. Menkes and
Wilson’s diseases are severe neurodegenerative conditions that demonstrate the importance of Cu
transport into the secretory pathway. Brain levels of Cu, which is almost entirely protein bound,
exceed extracellular levels by more than a hundred-fold. Cu stored in the secretory pathway is
released in a Ca2+-dependent manner and can transiently reach concentrations over 100 µM at
synapses. The ability of low µM levels of Cu to bind to and modulate the function of γ-
aminobutyric acid type A (GABAA) receptors, N-methyl-D-aspartate (NMDA) receptors and
voltage-gated Ca2+ channels contributes to its effects on synaptic transmission. Cu also binds to
amyloid precursor protein and prion protein; both proteins are found at synapses and brain Cu
homeostasis is disrupted in mice lacking either protein. Especially intriguing is the ability of Cu to
affect AMP-activated protein kinase (AMPK), a monitor of cellular energy status. Despite this,
few investigators have examined the direct effects of Cu on synaptic transmission and plasticity.
Although the variability of results demonstrates complex influences of Cu that are highly method-
sensitive, these studies nevertheless strongly support important roles for endogenous Cu and new
roles for Cu-binding proteins in synaptic function/plasticity and behavior. Further study of the
many roles of Cu in nervous system function will reveal targets for intervention in other diseases
in which Cu homeostasis is disrupted.
Cu is a necessity for eukaryotic life and tightly regulated in complex
organisms
Copper (Cu) is an essential trace element whose ability to donate and accept electrons gives
it great utility in multicellular life. It is thought that microorganisms evolved the ability to
utilize Cu when oxygen became more prevalent in the atmosphere and previously insoluble
Cu1+ was oxidized to bioavailable Cu2+ (Crichton and Pierre, 2001; Ridge et al., 2008).
Cleavage of dioxygen through reduction via Cu allowed these organisms to extract energy
from fuels more efficiently. This critical evolutionary juncture coincided with the
development of multicellular life (Decker and Terwilliger, 2000; Crichton and Pierre, 2001).
Cu has been an essential component of biology through the evolution of complex systems,
including the mammalian central nervous system.
Cu serves many functions in biology, but its unique role in oxidation-reduction reactions has
been the most extensively studied. An association between Cu and dioxygen-utilizing
enzymatic reactions accompanied the appearance of Cu in biological systems. Cu serves as
an essential co-factor for about a dozen enzymes (called cuproenzymes) encoded by
mammalian genomes. Cuproenzymes are structurally and functionally conserved from yeast
and worms to more complex organisms like mice and humans (Andreini et al., 2008).
Cytochrome c oxidase, a mitochondrial enzyme, is essential for oxidative phosphorylation
and aerobic respiration. Superoxide dismutase, a cytosolic enzyme, detoxifies free radicals.
Dopamine-β-monooxygenase (DβM), a secretory pathway enzyme, is essential for
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catecholamine biosynthesis, and peptidylglycine α-amidating monooxygenase (PAM),
another secretory pathway enzyme, is essential for peptide biosynthesis (Fig. 1).
However, the advantages of using Cu come at a price. The same reactive properties that give
Cu its utility as an enzymatic co-factor pose a risk for the generation of reactive oxygen
species and subsequent oxidative damage in uncontrolled settings (Uriu-Adams and Keen,
2005). An intricate network of Cu binding proteins and Cu transporters, whose numbers
vastly exceed the number of cuproenzymes, presumably evolved to minimize the potentially
detrimental effects of Cu (Andreini et al., 2008). The components of this Cu homeostasis
network and their interactions are just beginning to be uncovered (Banci et al., 2010;
Lutsenko, 2010; Kim et al., 2010). Importantly, striving to identify the components of this
network and elucidate their interactions is paramount in advancing our understanding of and
treatments for a range of diseases in which Cu handling and homeostasis are disrupted.
Genetic disorders of Cu homeostasis reveal the consequences of
dysregulation
The necessity for Cu and the potential for Cu toxicity are clearly demonstrated through the
symptoms associated with genetic disorders of Cu transport and dietary Cu deficiency/
toxicity. The two major genetic disorders, Menkes and Wilson’s disease, involve
dysfunction of the P-type ATPase transporters ATP7A and ATP7B, respectively. While
each protein can transport Cu into the secretory pathway, the pathophysiologies of these two
diseases are quite different, reflecting the distinct sites at which these two Cu transporters
are expressed.
Menkes Disease
Menkes disease is an X-linked recessive disorder first characterized by John Hans Menkes
in 1962 as an inherited form of Cu deficiency (MENKES et al., 1962)[OMIM 309400; for
review see (Kodama et al., 1999; de Bie et al., 2007; Kaler, 2011)]. Lack of ATP7A activity
in the gut results in diminished Cu uptake and causes Cu deficiency in the rest of the body.
Naturally occurring mutations in the human ATP7A gene span the full length of the protein
and impair its Cu transport function to varying extents, resulting in a continuum of
phenotypic severity (Kaler, 2011). Infants born with Menkes disease typically begin to
exhibit developmental delay and failure to thrive a few months after birth. Symptomology
associated with Menkes disease results from Cu deficiency in multiple organs and directly
reflects deficient activities of specific cuproenzymes. Moreover, symptom severity often
shares a close relationship with residual Cu transport activity (Donsante et al., 2007).
Symptoms progress until death at around 3 years of age.
ATP7A expression is developmentally and cell-type specifically regulated in the central
nervous system. In mice, expression of ATP7A is highest in the perinatal period and
declines between 2- and 10-fold into adulthood in a region-dependent manner (Niciu et al.,
2006). Neurons of the cortex, hippocampus, olfactory bulb, cerebellum and hypothalamus
express ATP7A (Ke et al., 2006; Niciu et al., 2006). Neuronal ATP7A is concentrated in the
perinuclear region, overlapping trans-Golgi network markers, and can be detected extending
into neurites in vitro (Schlief et al., 2005) and in vivo (Niciu et al., 2006). In non-neuronal
cells, ATP7A is expressed in the perinatal period and into adulthood (choroid plexus,
ependymal cells and a subset of astrocytes) or in the perinatal period only (cerebral
endothelial cells, microglia, optic nerve oligodendrocytes) (Niciu et al., 2006).
Seizures are common in Menkes patients, with occurrence and severity typically increasing
through the course of the disease (Kodama et al., 1999; de Bie et al., 2007; Kaler, 2011;
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Kodama et al., 2011). Brain energy metabolism is disrupted, as evidenced by reductions in
cytochrome c oxidase and other genes involved in oxidative phosphorylation (Liu et al.,
2005). Since energy metabolism is tightly related to neurotransmission and cellular
excitability (Pan et al., 2008; Cloix and Hevor, 2009), disruptions in energy metabolism
could influence Menkes-associated seizure susceptibility (Prasad et al., 2011). Deficiencies
of both DβM and PAM could contribute to seizure susceptibility through shifts in excitatory-
inhibitory balances caused by deficiencies in catecholaminergic and peptidergic
neuromodulators, respectively. Norepinephrine has potent anti-convulsive effects (Mason
and Corcoran, 1978; Mason and Corcoran, 1979), and destruction of noradrenergic neurons
of the locus coeruleus or genetic deletion of DβM lowers the threshold for epileptogenic
stimuli in limbic structures (Mishra et al., 1994; Szot et al., 1999). Inhibitory interneurons
express and secrete multiple neuropeptides (McDonald and Pearson, 1989; Salio et al.,
2006), many of which promote inhibition and/or reduce excitation [for review see (Bajorek
et al., 1986; Zadina et al., 1986)]; examples include neuropeptide Y (Bacci et al., 2002),
cholecystokinin (Crawley and Corwin, 1994), thyrotropin releasing hormone (Deng et al.,
2006) and vasopressin (Raggenbass, 2008). Reduced activity of PAM due to Cu
insufficiency leads to tissue-specific impairments in amidation and peptide bioactivity
(Bousquet-Moore et al., 2010). Thus Cu deficiency can contribute to Menkes-associated
epilepsy through multiple mechanisms.
Wilson’s Disease
Wilson’s disease is an autosomal recessive disorder first characterized by Samuel Alexander
Kinnier Wilson in 1912 as an inherited degenerative disease of the liver and brain [OMIM
277900; for review see (Fujiwara et al., 2006; Das and Ray, 2006; de Bie et al., 2007;
Pfeiffer, 2007; Lutsenko, 2010)]. Manifestations of Wilson’s disease result from multiple
organ dysfunction secondary to Cu overload, rather than Cu deficiency as with Menkes
disease, and typically arise in adolescence or adulthood. Dysfunction of the Wilson’s disease
protein, ATP7B, results in an inability to remove Cu from the body because hepatocytes
cannot excrete it into bile. Cu accumulates in the liver, enters the circulation unbound and
deposits in multiple organs. A striking example is Kayser-Fleischer rings, deposits of Cu in
the cornea, which are clinically considered pathognomonic for Wilson’s disease (de Bie et
al., 2007). Pathophysiology in Wilson’s disease primarily involves excessive oxidative stress
directly resulting from Cu overload in the liver and brain. Non-neurological manifestations
include symptomology commonly associated with liver failure and hemolytic anemia (Attri
et al., 2006; de Bie et al., 2007).
ATP7B is expressed in the brain, but is not as prevalent as ATP7A (Lutsenko et al., 2010).
The neuropathology involved in Wilson’s disease is thought to be due to Cu deposition in
the brain, which results in neurodegeneration. Changes in lenticular structures associated
with basal ganglia circuitry are most common and are detectable by magnetic resonance
imaging (Kodama et al., 2011). As such, motor symptoms include parkinsonism, dystonia,
ataxia, dysarthria, chorea and oculomotor defects (Das and Ray, 2006; Taly et al., 2007).
Seizures and progressive cognitive impairment are also common (Akil and Brewer, 1995;
Kodama et al., 2011).
Many Wilson’s disease patients present with psychiatric symptoms (Taly et al., 2007),
which may be severe enough for patients to reach diagnostic criteria for Axis I affective/
mood and/or anxiety disorders (Pfeiffer, 2007). Progression of Wilson’s disease is
associated with changes in personality and behavior and commonly includes increased
aggression, irritability, hostility and depressive-like symptoms (Akil and Brewer, 1995).
Wilson’s patients are commonly treated for psychiatric symptoms in conjunction with Cu
chelation therapy (Taly et al., 2007; Srinivas et al., 2008). Psychiatric manifestations of
Wilson’s disease are recapitulated in animal models; in the toxic milk mouse, a mutation in
Gaier et al. Page 3
J Neurosci Res. Author manuscript; available in PMC 2014 February 17.
N
IH
-PA Author M
anuscript
N
IH
-PA Author M
anuscript
N
IH
-PA Author M
anuscript
ATP7B results in elevated Cu in the limbic system, striatum and cerebellum, but not in the
cortex (Terwel et al., 2011). Toxic milk mice display motor impairment, disrupted learning
and memory, and less anxiety-like behavior. This animal model supports the notion that the
regional pattern of brain alterations in Wilson’s disease accounts for the prevalence of
emotional dysregulation in Wilson’s psychopathology.
Importantly, many of the symptoms of Wilson’s disease can be ameliorated by chelation
therapy (Akil and Brewer, 1995; Srinivas et al., 2008; Kodama et al., 2011). Although
neurodegeneration occurs eventually, the many neuronal and synaptic effects of elevated Cu
no doubt contribute to the reversible psychiatric manifestations associated with Wilson’s
disease. While genetic and dietary disorders of Cu homeostasis demonstrate the importance
of Cu in the nervous system, it is not clear that the role of Cu as an enzymatic co-factor
explains all the symptoms associated with these diseases.
Brain Cu homeostasis: from serum to synapse
Cu uptake in the gut is mediated primarily through CTR1 and, to a lesser extent, divalent
metal transporter 1 (DMT1) (Lutsenko, 2010; Kaler, 2011). In enterocytes, CTR1 plays an
essential role in the import of Cu from various ingested food sources including legumes,
liver, shellfish, nuts and chocolate (Linder and Hazegh-Azam, 1996; Ma and Betts, 2000). In
most cells, CTR1 plays an essential role in cellular Cu uptake into the cytosol (Fig. 1). Cu
then binds one of several cytosolic chaperones; each chaperone has a designated destination
for the Cu it carries. For example, antioxidant-1 (Atox-1, also known as HAH1) delivers Cu
directly to P-type ATPase transmembrane transporters ATP7A and ATP7B (Hamza et al.,
2001; Lutsenko et al., 2007). The liver acts as the main storage site for Cu; from the liver,
Cu can be mobilized to various organs or excreted following secretion into the bile duct
(Wijmenga and Klomp, 2004). The Cu-regulated targeting of ATP7B to apical vs.
basolateral vesicles determines whether Cu is exported in bile or made accessible to other
tissues by secretion into plasma. Cu secreted from the liver is typically loaded into newly
synthesized ceruloplasmin, a Cu-dependent secreted ferroxidase. Each ceruloplasmin
molecule binds 6 Cu ions, and 75–95% of the Cu in the blood is bound to ceruloplasmin
(Hellman and Gitlin, 2002; Bielli and Calabrese, 2002).
Cu entry into the brain requires CTR1 and ATP7A and occurs through two routes. The first
route is through the blood-brain barrier, which serves as a regulated junction between the
blood and the extracellular fluid of the brain parenchyma. The second is through the blood-
cerebral spinal fluid (CSF) barrier, which serves as the junction between the blood and the
CSF. CTR1 and ATP7A are expressed in endothelial cells of the blood-brain barrier and in
epithelial choroid plexus cells of the blood-CSF barrier (Choi and Zheng, 2009; Kaler,
2011). The values reported for the Cu content of normal human CSF vary widely, but are
generally below 1 µM (Table 1). Cu is less abundant in CSF than in serum. This difference
is likely influenced by overall protein levels of these two fluids since patients with CNS
pathology resulting in increased CSF protein also have increased CSF Cu (Kapaki et al.,
1989). Cu in the CSF is significantly elevated in patients with Alzheimer’s disease,
Parkinson’s disease, Amyotrophic Lateral Sclerosis (Hozumi et al., 2011), and perhaps
Multiple Sclerosis (Kapaki et al., 1989; Melo et al., 2003).
Like other metals such as Zn and Fe, Cu is highly concentrated in the brain (Que et al.,
2008). Only the liver, the body’s major organ for Cu storage, and the kidneys have higher
Cu concentrations than the brain, where total Cu levels are around 200 µM for each (Linder
and Hazegh-Azam, 1996; Lutsenko et al., 2010). Brain Cu levels increase in early post-natal
development. Whole brain Cu levels measured by inductively coupled mass spectroscopy
rise between 2 and 3.5 fold between infancy and adulthood (~0.8 µg/g at P0; ~28 µg/g at
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P20–40 wet weight) in Long Evans rats (Saito et al., 1995; Tarohda et al., 2004). The sharp
developmental increase in brain Cu corresponds to high levels of ATP7A expression in the
postnatal choroid plexus and ependymal cells of the ventricular system (Niciu et al., 2006).
That a single injection of Cu or viral transfection of ATP7A into the choroid plexus can
rescue the lethal phenotype of mouse models of Menkes disease (Donsante et al., 2011)
demonstrates the key role of brain Cu in early development.
Brain Cu levels vary in different regions (Table 2), reflecting varying expression of Cu
handling machinery (Niciu et al., 2006) and methodological differences that remain to be
resolved. Cu is generally 2-fold more abundant in grey matter than in white matter
(Prohaska, 1987). Using atomic absorption spectroscopy, the hypothalamus was found to
contain the highest Cu concentration in the rat brain (Rajan et al., 1976). Laser ablation
inductively coupled mass spectroscopy revealed an abundance of Cu in the medial
geniculate nucleus, superior colliculus, and periaqueductal grey in adult rats (Jackson et al.,
2006). High levels of Cu were observed in the lateral nucleus of the amygdala and
dorsomedial aspect of the diencephalon. Strain differences can produce 3-fold differences in
Cu concentrations in the murine hippocampus (Jones et al., 2008). The Cu content of the
human hippocampus is higher than other brain regions (Dobrowolska et al., 2008), with Cu
concentrated in the granule and pyramidal cell layers of the dentate gyrus and CA1 area. The
functional significance of regional and species-specific Cu distributions is unclear.
The intracellular concentration of brain Cu is 2–3 orders of magnitude higher than its
extracellular concentration (Que et al., 2008). Almost all brain Cu is protein bound, and its
distribution amongst different subcellular compartments is tightly regulated (Que et al.,
2008; Lutsenko et al., 2010). Cu levels are highest in cytosolic and mitochondrial fractions
(Rajan et al., 1976; Baerga et al., 1992). Cu is also abundant in synaptic vesicles, especially
in the cerebral cortex (Rajan et al., 1976). The abundance of Cu in synaptosomal and
endosomal fractions (Saito et al., 1995; Brown et al., 1997; Herms et al., 1999; Brown,
2003; Giese et al., 2005), suggests that Cu release and retrieval are an important part of how
Cu is used in the brain. In vitro, synaptosomes can take up Cu (Giese et al., 2005), and
membrane depolarization stimulates Cu release (Kardos et al., 1989).
Neuronal activation stimulates the Ca2+-dependent secretion of Cu (Hartter and Barnea,
1988; Schlief et al., 2005), which can reach concentrations of 100–250 µM within synapses
(Kardos et al., 1989). As discussed below, Cu can then bind to and influence the function of
synaptic and extra-synaptic proteins important to synaptic transmission and neuronal activity
(Mathie et al., 2006; Que et al., 2008; Tamano and Takeda, 2011). The regulated release of
Cu at synapses could contribute in a unique way to synaptic function and behavior.
Most of the work exploring the role of Cu in synaptic transmission and plasticity has been
conducted in the hippocampus. ATP7A is expressed at high levels in the pyramidal neurons
and interneurons of the neocortex and hippocampus (Schlief et al., 2005; Niciu et al., 2006),
where Cu content is also relatively high (Rajan et al., 1976; Bakirdere et al., 2010). Cu is
released from cultured hippocampal neurons in an N-methyl-D-aspartate (NMDA) receptor-
dependent manner, and stimulation of NMDA receptors results in the trafficking of ATP7A
out of the late Golgi into dendrites (Schlief et al., 2005; Dodani et al., 2011). Since NMDA
receptor activity is crucial for different forms of synaptic plasticity and learning and memory
(Malenka and Bear, 2004; Yashiro and Philpot, 2008), Cu is very likely to be present at
synapses during learning. Despite this, few groups have explored the direct role of Cu in
synaptic transmission, plasticity or learning and memory.
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Effects of exogenous Cu on synaptic transmission
In order to study the role of Cu in synaptic transmission, many investigators have employed
the use of exogenous Cu. Doreulee and colleagues (Doreulee et al., 1997) bath-applied 1–
100 µM CuSO4 onto hippocampal slices while monitoring synaptic transmission in the
Schaffer collateral-CA1 pathway using extracellular recording methods. They found that 10
µM CuSO4 was needed to depress α-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid
(AMPA) receptor-mediated transmission, while NMDA receptor-mediated signals were
sensitive to 1 µM CuSO4. Intracellular recordings confirmed these results. Presynaptic
glutamate release and γ-aminobutyric acid (GABA) mediated inhibition were insensitive to
10 µM and 1 µM CuSO4, respectively. CuCl2 (30 µM) had depressing effects on excitatory
synaptic transmission, similar to CuSO4, in cultured olfactory bulb neurons (Trombley et al.,
1998; Horning and Trombley, 2001). These effects occurred very rapidly and were
attributed to direct effects of Cu2+ on voltage-gated ion channel and synaptic receptor
functions.
In a recent study, Peters and colleagues (Peters et al., 2011) characterized a biphasic
response of cultured rat hippocampal neurons to 10 µM CuCl2. Acute Cu application had a
depressive effect, as reported previously in the hippocampus and other brain regions (Xie et
al., 1993; Doreulee et al., 1997; Horning and Trombley, 2001); AMPA receptor mediated
synaptic transmission was blocked in a concentration-dependent manner and the frequency
and amplitude of spontaneous excitatory currents were reduced. Interestingly, the opposite
effect was observed when CuCl2 was applied for 3 hours prior to recordings; spontaneous
and evoked AMPA receptor and GABAA receptor mediated currents were enhanced. The
excitatory effect was mediated by increases in pre-synaptic release of glutamate and post-
synaptic expression of AMPA receptor complexes. Both the GluR1 subunit of the AMPA
receptor and PSD95 were increased in hippocampal cultures treated with CuCl2 for 3 hours
as assessed by Western blot and immunocytochemistry. This effect was not due to
compensatory effects following acute synaptic suppression by Cu, since similar long-term
effects could not be replicated by selective blockade of AMPA and GABAA receptors. This
study provides comprehensive evidence of the profound and complex effects of exogenous
Cu on synaptic transmission and strongly supports an important role for endogenous Cu in
vivo.
Leiva et al 2000 (Leiva et al., 2000) used extracellular recordings to investigate the effects
of exogenous CuSO4 on mixed excitatory and inhibitory signals in acute hippocampal slices.
CuSO4 (10 µM) application reduced the amplitude and duration of mixed signals.
Bicuculline methiodide and picrotoxin, both of which are GABAA receptor antagonists, had
opposite effects on these mixed signals in the Schaffer-CA1 pathway; bicuculline reduced
mixed transmission similar to CuSO4, whereas picrotoxin enhanced these signals. These two
compounds work through very different mechanisms; bicuculline competitively antagonizes
the GABA binding site, whereas picrotoxin acts to non-competitively block the Cl− channel
pore of the GABAA receptor (Krishek et al., 1996) (Fig. 2). The effect of CuSO4 and
bicuculline together was not greater than either alone, suggesting that Cu works through
GABAA receptors to depress synaptic transmission. By contrast, addition of CuSO4 with
picrotoxin remarkably enhanced synaptic transmission above what was observed with
picrotoxin alone (Leiva et al., 2000). The plethora of GABAA receptor subtypes, which are
located on different classes of neurons, different neuronal domains and have different
physiological functions and pharmacological profiles complicates interpretation (Zhang et
al., 1995; Martina et al., 2001; Farrant and Nusser, 2005). Nevertheless, it is clear that the
ability of Cu2+ to bind to GABAA receptors contributes to its complex effects on synaptic
transmission (see below).
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Protein targets for synaptically released Cu
While the synaptic effects of Cu are impressive and profoundly complex, very little is
known about the molecular mechanisms underlying these effects. Several synaptically
localized molecules that bind Cu could mediate non-enzymatic effects of Cu on neuronal
signaling.
Glutamate receptors
Receptors for glutamate include a heterogeneous family of tetrameric ligand gated ion
channels categorized by their pharmacological profiles as AMPA, kainate and NMDA
receptors (Scott and Ehlers, 2004). All ionotropic glutamate receptors are non-specific
cation channels that act to depolarize the membrane. Their unique subunit composition
contributes to their distinct pharmacological and kinetic properties as well as their ionic
permeability. For example, AMPA receptors containing the GluR1 subunit and NMDA
receptors are permeable to Ca2+ in addition to Na+ and K+, and thus contribute to Ca2+-
dependent intracellular signaling pathways including gating synaptic plasticity (Kullmann et
al., 2000).
Weiser and Wienrich (Weiser and Wienrich, 1996) examined the effects of Cu2+ (salt
unspecified) on AMPA and NMDA receptor mediated currents in cultured rat cortical
neurons. Cu2+ inhibited both receptors independent of membrane voltage, but through
distinct mechanisms. The IC50 values for AMPA and NMDA receptors were 4.3 and 15 µM
Cu2+, respectively, and near complete blockade was achieved at 100 µM Cu2+. Cu2+ shifted
the agonist concentration-response curve toward higher agonist concentrations; the effect
was most consistent with a 2 binding site model for Cu2+ inhibition of AMPA receptors.
Since the effects of Cu2+ on AMPA receptors were greatly diminished and more rapidly
reversed by the reducing agent dithiothreitol (DTT), an oxidative mechanism may be
involved. Increasing concentrations of Cu2+ had a similar effect on NMDA receptor agonist
concentration-responses. Since the ability of Cu2+ to inhibit NMDA receptor mediated
currents was not affected by DTT, the mechanism is thought to be oxidation-independent.
Inhibitory effects of Cu2+ on NMDA receptor mediated currents were also observed in
acutely isolated olfactory bulb neurons (Trombley and Shepherd, 1996) and in cultured
mouse and rat hippocampal neurons (Vlachova et al., 1996); the IC50 values in these studies
(30 µM and 0.27 µM CuCl2, respectively), differed significantly. The latter study concluded
that Cu2+ inhibition of the NMDA receptor occurs non-competitively and with preference
for agonist-bound receptors (Vlachova et al., 1996).
The inhibitory effect of Cu2+ on NMDA receptors was later shown to depend on
nitrosylation of the NMDA receptor, which is facilitated in the presence of CuCl2 (Schlief et
al., 2005). In a separate set of experiments, Schlief and colleagues found that a high
concentration of CuCl2 (200 µM) abrogates NMDA receptor-mediated excitotoxicity of
primary rat hippocampal cultured neurons (Schlief et al., 2006). Cultured hippocampal
neurons prepared from mice expressing the mutant mottled/brindled Atp7a are more
susceptible to NMDA receptor mediated excitotoxic injury. An additional mechanism for
Cu2+ inhibition of NMDA receptors involving the prion protein has recently been suggested
(described below) (You et al., 2012).
GABAA receptors
GABAA receptors are heteropentameric ionotropic receptors structurally similar to nicotinic
acetylcholine receptors (Hevers and Luddens, 1998; Jacob et al., 2008). There are 18
subunits identified to date, and alternative splicing contributes additional diversity. GABAA
receptors contain two α subunits (α1-α6), two β subunits (β1-β3) and a single γ(γ1-γ3), δ,
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ε(ɛ1-ɛ3), θ or π subunit (Fig. 2A). Importantly, subunit composition determines GABAA
receptor localization, activity and function within neurons and networks (Wafford et al.,
2004; Rudolph and Mohler, 2006). Each subunit has a large extracellular N-terminal domain
(NTD) which includes a short cysteine loop and 4 transmembrane domains (TMD; TMD2
lines the channel pore); a long intracellular loop between TMD3 and TMD4 acts as a site for
protein-protein interactions and post-translational modifications that regulate trafficking and
channel activity (Fig. 2B) (Jacob et al., 2008). The binding of GABA at both interfaces
between the NTDs of the α and β subunits leads to channel pore opening and the passage of
Cl− ions inhibits action potential activity.
Physiological concentrations of Cu2+ bind to and inhibit GABAA receptor activity (Ma and
Narahashi, 1993; Sharonova et al., 1998; Kim and Macdonald, 2003). Unlike Zn2+, which
displays subtype preference for binding (α6, EC50 = 1.9 µM; α1 EC50 = 10.4 µM) (Fisher
and Macdonald, 1998), Cu2+ binds each human GABAA receptor subtype with equal
affinity (EC50 ~ 2.4 µM) (Kim and Macdonald, 2003). Cu2+ and Zn2+ both have inhibitory
effects on GABAA receptor function (Narahashi et al., 1994; Trombley et al., 1998; Horning
and Trombley, 2001) [for review see (Mathie et al., 2006)]. Cu2+-mediated inhibition of
GABAA receptors is reversible (Ma and Narahashi, 1993), but may require chelator-
mediated removal of Cu2+ (Sharonova et al., 1998).
Competing inhibitory effects of Cu2+ and Zn2+ on GABAA receptor function strongly
suggest that they act through similar mechanisms (Ma and Narahashi, 1993; Narahashi et al.,
1994; Fisher and Macdonald, 1998). Although Cu2+ inhibition of GABA-activated currents
follows kinetics similar to competitive antagonists, the Cu2+ binding site is distinct from the
GABA binding site (Sharonova et al., 1998; Sharonova et al., 2000) (Fig. 2). Cu2+ acts by
inhibiting the effects of GABA on channel gating. Cu2+ binding also influences the binding
and activity of other GABAA receptor allosteric modulators such as benzodiazepines
(Mizuno et al., 1982; Kardos et al., 1984). The Cu2+ binding site includes a Val134-Arg(Gln
for α2)-Ala-Glu-Cys-Pro-Met-His141 motif, which includes the Cys-loop in the α1 NTD
(Fig. 2B) (Kim and Macdonald, 2003). Val134, Arg/Gln135 and His141 are the most
important determinants for Cu2+ binding, but the whole motif is required for the full Cu2+
effect (Fig. 2B). A residue in the β3 subunit (His267 in TMD2) and another residue in the α6
subunit (His273 in the TMD2-TMD3 loop) are important for both Cu2+ and Zn2+ binding
(Kim and Macdonald, 2003); not all of the residues essential for Zn2+ binding are required
for Cu2+ binding (Fisher and Macdonald, 1998). Taken together, these data suggest that
Cu2+ and Zn2+ inhibit GABAA receptor function through overlapping but non-identical
binding sites.
The subtype specificity of Cu2+ and Zn2+ binding to GABAA receptors is functionally
relevant. GABAA receptors that contain α(1–3) are synaptically localized and mediate
phasic or fast inhibition, whereas α(4–6)-containing receptors are extra-synaptic and
mediate tonic or slow inhibition (Hevers and Luddens, 1998; Farrant and Nusser, 2005;
Jacob et al., 2008). Cu2+ has a stronger maximal effect on α1/α2-containing GABAA
receptors than on α4/α6-containing receptors (Kim and Macdonald, 2003). In contrast, Zn2+
has a stronger affinity for α6-containing receptors than for α1-containing receptors but has
similar maximal inhibitory efficacies (Fisher and Macdonald, 1998). Subtype-specific
localization of GABAA receptors will determine the effect of Cu2+ on any given neuron. For
example, in hippocampal pyramidal neurons, α1-containing GABAA receptors localize to
parvalbumin-positive axo-somatic synapses while α2-containing receptors localize to
cholecystokinin/vasoactive intestinal peptide-positive axo-axonic synapses (Nyiri et al.,
2001). α5-containing GABAA receptors are also expressed by hippocampal pyramidal
neurons and localize to the base of dendritic spines (Rudolph and Mohler, 2006) (Fig. 3).
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Amyloid precursor protein (APP)
APP, whose proteolytic cleavage yields the pathological Aβ peptide, is implicated in
Alzheimer’s disease pathology. The extracellular domain of APP binds Cu2+ [applied as
Cu(NO3)2] with attomolar affinity (Atwood et al., 2000) while the intracellular domain is
critical to APP trafficking to and from the plasma membrane (Guo et al., 2012). APP is
concentrated in the endoplasmic reticulum of neurons, but endogenous APP
immunoreactivity can be appreciated in dendritic as well as somatic domains of cortical,
hippocampal and cerebellar neurons (Guo et al., 2012). Cu2+-glycine (1 µM) promotes the
proteolytic cleavage of APP to yield Aβ, and Aβ-mediated neuronal toxicity is enhanced in
the presence of Cu2+ (Huang et al., 1999). A connection between APP and Cu homeostasis
became apparent when cortical Cu levels in mice lacking APP were shown to increase to
approximately 150% of wildtype levels (White et al., 1999). APP over-expression results in
a reduction of total brain Cu by 14% (Maynard et al., 2002). High levels of CuCl2 (150 µM)
promote cell surface expression of APP and its distribution into neurites, but had no effect
on APP proteolytic processing in cultured cortical neurons (Acevedo et al., 2011). APP
clearly plays an important but poorly understood role in Cu homeostasis; its dendritic
localization and avidity for Cu2+ suggest a role for APP in Cu-mediated modulation of
synaptic transmission and plasticity (Fig. 3).
Prion protein (PrP)
PrP, another Cu-binding transmembrane protein, is involved in spongiform encephalopathies
such as Creutzfeldt-Jakob disease [for review see (Vassallo and Herms, 2003; Zomosa-
Signoret et al., 2008). PrP is pre- and post-synaptically expressed in neurons and contains 5
sites that bind Cu2+ with high nM to low µM affinity (Fig. 3) (Herms et al., 1999; Zomosa-
Signoret et al., 2008). The binding of Cu2+ to PrP triggers internalization of the
metalloprotein complex. Genetic deficiency of PrP in mice results in a reduction of
synaptosomal Cu to 60% of wildype levels, but total Cu levels remain unchanged (Herms et
al., 1999; Giese et al., 2005). However, reduced total Cu levels in PrP null mice have also
been reported (Brown, 2003); this discrepancy may be age-dependent or result from
methodological differences. The electrophysiological phenotype of these mice included
impaired LTP and reduced GABAergic inhibition in the hippocampus (Collinge et al.,
1994). Interestingly, the synaptic plasticity deficit of PrP null mice corresponds with
impaired spatial learning and memory consolidation (Criado et al., 2005). While PrP clearly
plays a role in Cu homeostasis, the details and significance of its role are not yet understood
(Zomosa-Signoret et al., 2008) (Fig. 3). The Cu binding capacity of APP and PrP are not
only highly suggestive of their role in Cu homeostatic disease states, but also implicate a
pathophysiological role for disrupted Cu homeostasis in Alzheimer’s and prion-related
diseases.
A Cu-mediated interaction between the neurotoxic Aβ peptide, PrP, and NMDA receptors
was recently revealed using cultured rat hippocampal neurons (You et al., 2012).
Application of either Aβ peptide (1 µM) or a Cu-specific chelator [bathocuproine
disulphonate (BCS); 10 µM] similarly enhanced steady-state NMDA receptor currents,
which contributed to neuronal death assayed by TUNEL staining. Co-application of Aβ
peptide and BCS lacked any additive effect, suggesting action through a common
mechanism. Genetic or proteolytic elimination of PrP increased baseline NMDA receptor
steady-state current and abolished the enhancing effects of both Aβ peptide and BCS, laying
the foundation for a regulatory role of PrP. The Cu-dependent co-immunoprecipitation of
PrP with the obligate NR1 subunit of the NMDA receptor revealed a potential mechanism.
The NR1 subunit contains a binding site for the co-agonist Gly, whose affinity for the
NMDA receptor was enhanced in the absence of PrP. Together these data paint a compelling
picture of PrP-dependent regulation of NMDA receptors that is pathologically disrupted in
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the presence of Aβ through the sequestration of Cu (Fig. 3). The authors highlight the
implications of these results for neurodegenerative diseases, especially Alzheimer’s disease.
Additionally, these results suggest a new direct mechanism by which Cu deficiency can
contribute to hyperexcitability to precipitate seizure activity. This study also provides
notable mechanistic insight into the complex influences of Cu on synaptic transmission and
plasticity given the well-established role of NMDA receptor function in gating synaptic
plasticity and learning and memory (see below) (Zajaczkowski et al., 1997).
TrkB/Brain-derived neurotrophic factor (BDNF)
Brain-derived neurotrophic factor (BDNF), a potent stimulant of neuronal and synaptic
growth, is important in brain development, learning and memory [for review see
(Minichiello, 2009)]. BDNF is released upon activity-dependent neuronal stimulation and
binds to tropomyosin-receptor kinase B (TrkB) receptors (Fig. 4), inducing their
autophosphorylation and activation. TrkB receptors expressed on cultured cortical neurons
are phosphorylated/activated in response to exposure to CuCl2 for 15 min (Hwang et al.,
2007). A maximal response is observed with 10 µM CuCl2, and Cu is more effective than
several other metals, including Zn. CuCl2 enhances proBDNF release and proteolytic
processing to yield mature BDNF. Both effects depend on the activity of matrix
metalloproteinases 2 and 9 (MMP2, MMP9), extracellular Zn-dependent endopeptidases. An
interesting aside is that BDNF signaling enhances hippocampal and cortical post-synaptic
NMDA receptor activity (Madara and Levine, 2008), which could lead to further Cu release
and TrkB activation. Thus, under certain conditions Cu could positively influence LTP
through TrkB signaling (Fig. 4).
Matrix metalloproteinases
MMPs contribute to synaptic plasticity through additional mechanisms. MMP-9 activation is
activity-dependent in the hippocampus and is necessary and sufficient for hippocampal LTP
and learning and memory (Nagy et al., 2006; Bozdagi et al., 2007; Nagy et al., 2007).
Moreover, MMP-9 deficient mice lack hippocampal LTP, but respond to LTP induced by
bath application of recombinant MMP-9 (Nagy et al., 2006). These results were later
corroborated with an MMP-9-dependent increase in dendritic spine volume which typically
accompanies increases in synaptic strength (Wang et al., 2008). This effect of MMP-9 is
mediated through its cleavage of ICAM-5, a post-synaptic integrin and negative regulator of
synaptic strength and growth (Conant et al., 2010). Thus, activation of MMP-9 during LTP
reduces the inhibitory effects of ICAM-5 on synaptic strength and growth. Neuronal, but not
glial, MMP-9 is specifically activated by 10 µM CuCl2 (Hwang et al., 2007), but it remains
to be determined whether this MMP/ICAM-5/LTP pathway requires or is modulated by the
release and extracellular availability of Cu (Fig. 4).
Adenosine monophosphate (AMP)-activated protein kinase (AMPK)
As discussed above, extracellular Cu can affect cytosolic signal transduction pathways
through its effects on NMDA receptors and MMPs. AMPK is a sensor used by eukaryotic
cells to regulate cellular energy; in response to the AMP/ATP ratio, AMPK acts on multiple
downstream pathways to increase net ATP production (Fig. 4). Cytosolic AMPK exists as a
heterotrimer comprised of a catalytic α, and regulatory β and γ subunits (Spasic et al., 2009;
Green et al., 2011). AMPK becomes activated via binding of AMP or by phosphorylation by
upstream kinases such as Ca/calmodulin-dependent protein kinase kinase β (CaMKKβ)
(Green et al., 2011). CaMKKβ is expressed in neuronal tissue and is activated by cytosolic
Ca2+ supplied through the NMDA receptor (Thornton et al., 2011). Dietary Cu deficiency
promotes AMPK activation and mitochondrial impairment in rat cerebellar tissue (Gybina
and Prohaska, 2008). Interestingly, this effect occurs without a change in the AMP:ATP
ratio, suggesting that Cu status influences AMPK activity through a parallel pathway. The
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Cu chaperone for superoxide dismutase (CCS; Fig. 1) is up-regulated in the Cu deficient
cerebellum (Gybina and Prohaska, 2008), and SOD1 expression reduces superoxide-
mediated activation of AMPK in cell cultures (Han et al., 2010). Thus AMPK activity is
mediated through multiple Cu-dependent mechanisms.
AMPK has many downstream targets whose effects are primarily aimed at enhancing ATP
synthesis and limiting cellular energy expenditure (Spasic et al., 2009). In neurons,
important energy consumers include the maintenance of ion gradients and neuronal
membrane activity. As such, AMPK activity limits neuronal activity through GABAB
receptors (Fig. 4). GABAB receptors are heterodimeric G protein-coupled receptors whose
extracellular binding of GABA induces inhibitory effects at pre- and post-synaptic sites
(Terunuma et al., 2010a). Post-synaptically, GABAB receptors are coupled to inward
rectifying K+ (GIRK) channels whose activity shunts propagating excitatory signals. In
hippocampal neurons, AMPK activation with AMP or metformin prolongs GIRK channel
activity via phosphorylation at Ser783 of the GABAB receptor 2 subunit (Kuramoto et al.,
2007). However, others have shown that prolonged activation of NMDA receptors promotes
internalization and degradation of GABAB receptors, presumably through protein
phosphatase 2-mediated dephosphorylation of the same site (Terunuma et al., 2010b). This
relationship is reciprocal, since GABAB receptor-mediated inhibition is a particularly
important regulator of NMDA receptor mediated Ca2+ signals critical to LTP (Morrisett et
al., 1991). The fact that Cu can influence the NMDA receptor/AMPK/GABAB receptor
pathway at multiple points speaks to the likelihood that Cu plays an intricate role in
modulating synaptic physiology and therefore behavior.
Roles of Cu in synaptic plasticity and behavior
Cu and synaptic plasticity
Exogenous Cu has consistently been shown to inhibit hippocampal long-term potentiation
(LTP), a form of synaptic plasticity hypothesized to be important for learning and memory
(Malenka, 2003; Lynch, 2004). Doreulee and colleagues (Doreulee et al., 1997) found that
the depressing effects of Cu on NMDA receptors had consequences for LTP, which was
prevented by 1 µM CuSO4 in the bath. Goldschmith and colleagues (Goldschmith et al.,
2005) confirmed the inhibitory effects using brain slices generated from rats receiving
elevated levels of dietary Cu (8–12 mg/day) for 20–25 days. Years later, the same groups
tested the effects of chronically injected Cu (1 mg/kg, i.p.) on hippocampal LTP with similar
results (Leiva et al., 2009). It was reported in both studies that Cu levels were more than 10-
fold higher in the brains of Cu supplemented rats than in control rats, raising concerns of Cu
toxicity. Nevertheless, it was concluded that elevated levels of Cu suppress LTP at Schaffer-
CA1 synapses.
NMDA receptor-independent inhibition of LTP by Cu occurs in acute slices of mouse CA1
and CA3 regions of the hippocampus (Salazar-Weber and Smith, 2011). In this case, Cu2+
may block LTP through inhibition of high-voltage gated Ca2+ channels, which are sensitive
to CuCl2 at an IC50 of ~1 µMin acutely dissociated rat cortical (Castelli et al., 2003) and
olfactory bulb neurons (Horning and Trombley, 2001). In particular, L-type voltage-gated
Ca2+ channels, which are located post-synaptically on dendrites and dendritic spines and
contribute to Ca2+ influx during LTP induction (Kullmann et al., 2000; Malenka and Bear,
2004), are sensitive to 10 µM CuCl2 (Korte et al., 2003). Interestingly, this interaction may
also depend on PrP (Korte et al., 2003). Thus Cu may impair LTP through multiple
mechanisms (Figs. 3,4).
The physiological roles of Cu in the hippocampus are clearly complex. Acute CuCl2
application to hippocampal slices has no effect on paired-pulse facilitation (Doreulee et al.,
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1997; Salazar-Weber and Smith, 2011). However, NMDA receptor-independent LTP
induction in the presence of 5 µM CuCl2 enhances paired pulse-facilitation and paired-pulse
depression in CA1 and CA3 regions of the hippocampus, respectively (Salazar-Weber and
Smith, 2011). To determine the effect of Cu on established LTP, Leiva and colleagues
(Leiva et al., 2003) waited until 90 min after LTP induction to bath apply 10 µM CuSO4,
which decreased synaptic efficacy as observed previously. Upon washout, the synaptic
response returned at a substantially larger size. While these findings are difficult to interpret,
they clearly demonstrate separate activity-dependent synaptic effects of Cu that have
complex influences on synaptic plasticity. In a separate set of experiments performed by the
same group, paired pulses were applied to Schaffer collaterals at intervals ranging from 20
to 300 ms in hippocampal slices generated from rats on normal or chronic Cu supplemented
diets (Goldschmith et al., 2005). Paired pulse facilitation decreased in both groups following
LTP induction, representing enhancement of pre-synaptic release probability. However, this
change was blunted in Cu supplemented animals, and paired pulse ratios were reduced in Cu
supplemented animals at baseline. These results are consistent with enhanced pre-synaptic
release probability at baseline with Cu supplementation and support an alternative
interpretation of occluded rather than impaired LTP. The contrast between the synaptic
effects of Cu applied in vitro and in vivo are difficult to reconcile, but together may suggest
a dual effect of Cu on synaptic plasticity in the hippocampus, where Cu prevents the
induction of new LTP and may reinforce LTP that has already been established.
These findings are consistent with biochemical evidence of the inhibitory effect of Cu2+ on
key molecules involved in LTP induction. The NMDA receptor acts as a coincidence
detector for synaptic activity and post-synaptic excitability. Unlike the majority of its
glutamate receptor counterparts, NMDA receptors are permeable to Ca2+, which triggers a
cascade of signaling events that ultimately lead to changes in post-synaptic receptor
expression and/or pre-synaptic release probability (Malenka, 2003; Yashiro and Philpot,
2008). Schlief and colleagues (Schlief et al., 2005) found that NMDA receptor activation
promoted the movement of ATP7A into dendrites and the ATP7A-dependent release of Cu
from primary hippocampal neurons. Importantly, the effect of NMDA receptor activation on
ATP7A expression was Cu-independent since the experiment was conducted in the presence
of the Cu-specific chelator BCS. Together these data demonstrate that the relationship
between NMDA receptor activity and Cu homeostasis is bidirectional, and this relationship
strongly supports a physiological role for Cu in synaptic plasticity and learning and memory.
Cu and behavior
Despite the consistent and striking observations made to this point in vitro, a direct
behavioral effect of Cu on hippocampal-dependent learning and memory has not yet been
demonstrated. Leiva and colleagues 2009 (Leiva et al., 2009) showed that the same chronic
Cu injection regimen had no effect on performance in the Morris water maze task, a
cognitive behavioral task testing working and long-term spatial (hippocampal-dependent)
memory. Neither dietary Cu supplementation (1 ppm CuSO4 in the drinking water) nor Cu
chelation (using 0.1% D-penicillamine dissolved in the drinking water) had an effect on
shuttle-box avoidance learning by rats (Fujiwara et al., 2006). Dietary Cu supplementation
alone is anxiolytic and reduced sensorimotor gating performance in the same study. Along
the same lines, mild dietary Cu restriction (0.6 ppm food Cu for 9–10 weeks) in mice has an
anxiogenic effect in the elevated zero maze (Bousquet-Moore et al., 2010). The same dietary
Cu restriction regimen also enhances sensitivity to pentylenetetrazol-induced seizures,
consistent with the seizure-prone Menkes phenotype. Dietary supplementation with Zn,
which competes with Cu for uptake in the gut, impaired fear learning and memory in normal
mice and spatial learning and memory in an Alzheimer’s mouse model (Railey et al., 2010;
Railey et al., 2011). Consistent with the idea that Zn supplementation induces Cu deficiency,
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the deficits in fear learning were alleviated with Cu supplementation (Railey et al., 2010).
Thus the strength of dietary challenge can weigh heavily on behavioral assessment of the
role of Cu in brain function.
The mammalian hippocampus possesses a uniquely high density of NMDA receptors,
specifically at the Schaffer-CA1 synapse (Meoni et al., 1998). As such, LTP at Schaffer-
CA1 synapses is characteristically reliant on NMDA receptor-mediated signaling. However,
LTP in other brain regions such as the cortex and amygdala does not rely as heavily on
NMDA receptors, and may thus respond differently to the levels of Cu available. NMDA
receptor-independent LTP may also respond differently in the presence of Cu even within
the hippocampus. Therefore, the roles of Cu in synaptic plasticity and learning and memory
are complex and likely region-specific, which may account for the array of symptoms
observed in disorders involving disrupted Cu homeostasis including Alzheimer’s disease,
prion disease, and Wilson’s disease [for review see (Uriu-Adams and Keen, 2005)].
Conclusions
The arrival of Cu on the biological scene before the need for a nervous system indicates that
Cu was available as the complex neuronal signaling pathways we see today evolved. The
reactivity of this metal and its unique association with metabolic processes dependent on
molecular oxygen, combined with its presence at synapses suggest many roles for
endogenous Cu in normal brain function. Studies performed to date reveal a complex
network of interconnected pathways through which Cu can both serve as a signal itself and
modulate signaling through multiple pathways. Additional studies will undoubtedly reveal
more Cu-responsive pathways than the limited studies done to date. Common neurological
diseases like Alzheimer's disease, with cognitive and behavioral symptomology, involve
pathology in which Cu homeostasis is disrupted. Thus, there is a need for further
investigation into the complex network of Cu signaling and pathways responsive to Cu in
the brain. Advancement of our understanding of these mechanisms will help identify new
molecular targets for neurological and psychiatric diseases, many of which currently have
few and poor treatment options, and will provide great insight into the basic mechanisms
through which humans interact with and experience the world.
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Fig. 1.
Key organelles and proteins involved in cellular Cu homeostasis. (Left) Cu enters cells
through the Cu-specific transporter CTR1. Intracellular Cu is buffered by metallothioneins.
Designated Cu chaperones deliver Cu to specific cuproenzymes in their respective
organelles. Cox17 delivers Cu to COX in mitochondria. SOD1 is the only cytosolic
cuproenzyme and receives Cu through CCS. Atox-1 delivers Cu to an ATPase (ATP7A or
ATP7B) that transport Cu into the secretory pathway (Right). Cu is present in secretory
granules along with cuproenzymes like DβM, extracellular SOD3 and PAM. Based on the
localization of ATP7A and ATP7B, Cu is also present in constitutive vesicles and in
endocytic compartments. APP and BDNF are also part of the secretory pathway in neurons
(see Figs. 3,4). Abbreviations: APP, amyloid precursor protein; Atox-1, antioxidant-1 (a.k.a.
HAH1); ATP7A, Menkes disease protein; CCS, Cu chaperone for SOD1; COX, cytochrome
c oxidase; Cox17, Cu chaperone for COX; CTR1, Cu transporter 1; DβM, dopamine β-
monooxygenase; ER, endoplasmic reticulum; LDCV, large dense-core vesicle; PAM,
peptidylglycine α-amidating monooxygenase; SOD1, superoxide dismutase 1; SOD3,
superoxide dismutase 3; TGN, trans Golgi network.
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Fig. 2.
GABAA receptor structure and Cu binding. (A) Ionotropic receptors for γ-aminobutyric acid
(GABA) are referred to as GABAA receptors and are heteropentameric receptors that are
permeable to Cl and thus generally serve an inhibitory function in the adult nervous system.
GABAA receptors typically comprise two α, two β, and one γ (or other) subunits, as
depicted on the left. On the right, a schematic view of the top of the channel demonstrates
the central ion pore (white), five subunits (each with four transmembrane domains;
TMD1-4), and approximate binding sites for GABA, Cu, barbiturates and benzodiazepines.
(B). Schematic of a single GABAA receptor subunit. Specific residues important for Cu
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binding are labeled according to subunit type (α and β). Phosphorylation of the cytoplasmic
loop between TMD3 and TMD4 regulates trafficking of the GABAA receptor.
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Fig. 3.
Roles of Cu in synaptic function. Cu enters cells through CTR1 and binds to cytosolic
chaperones including Atox-1, which delivers Cu to ATP7A. Cu gains entry into the
secretory pathway through ATP7A and is stored in LDCVs along with secreted
cuproenzymes DβM, SOD3 and PAM. Influx of Ca2+ through NMDARs and VGCCs results
in LDCV release and Cu secretion. This calcium signal also facilitates long-term
potentiation post-synaptically. Extracellularly, Cu has inhibitory effects on NMDARs,
VGCCs and GABAARs. Cu binds PrP and APP, which are located at synapses. Upon
binding of Cu, PrP can be internalized or can interact with the NR1 subunit of the NMDA
receptor, attenuating ion flux. APP binds Cu at attomolar concentrations, facilitating the
multiple cleavages that yield extracellular Aβ, which also binds Cu with high affinity. Aβ
can abrogate the inhibitory effect of PrP on the NMDA receptor by sequestering Cu or by
binding to PrP. Abbreviations: Aβ, beta amyloid peptide; AMPAR, 2-amino-3-(5-methyl-3-
oxo-1,2- oxazol-4-yl)propanoic acid receptor; APP, amyloid precursor protein; Ca++,
calcium; CTR1, Cu transporter 1; GABAAR, γ-aminobutyric acid A receptor; LDCV, large
dense-core vesicle; NMDAR, N-methyl-D-aspartate receptor; PrP, prion protein; PSD, post-
synaptic density; VGCC, voltage-gated Ca++ channel.
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Fig. 4.
Potential mechanisms for Cu effects on synaptic transmission. After uptake, Cu bound to
CCS is delivered to cytosolic SOD1 and Cu bound to Cox17 is delivered to mitochondrial
COX. AMPK, a cellular energy sensor, is activated by superoxide and high AMP levels;
SOD1 lowers superoxide levels and COX synthesizes ATP, reducing AMPK activity.
AMPK phosphorylates GABAB receptors, which facilitates the downstream GIRK channel
activation that mediates slow inhibition. Prolonged activation of NMDARs has the opposite
effect on slow inhibition by promoting internalization of GABAB receptors via protein
phosphatase 2 (not shown). Cu is also delivered to LDCVs via Atox-1 and ATP7A. Cu
stored in vesicles is released through Ca2+-dependent mechanisms. Extracellular Cu
stimulates MMP9, which facilitates the activation and release of BDNF. BDNF can bind to
and activate TrkB receptors, which can enhance NMDAR-mediated currents and facilitate
LTP. Abbreviations: AMP, adenosine monophosphate; AMPK, AMP-activated kinase;
ATP, adenosine triphosphate; BDNF, brain-derived neurotrophic factor; COX, cytochrome c
oxidase; GABABR, γ-amino butyric acid B receptor; GIRK, G protein-coupled inward
rectifying potassium; MMP9, matrix metalloproteinase 9; SOD1, superoxide dismutase 1;
TrkB, tropomyosin receptor kinase B.
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Table 1
Concentration of Cu in normal human cerebrospinal fluid
Data from several studies are summarized; subjects were all adults. ICP-MS, inductively coupled mass
spectroscopy (ICP-MS); HR-ICP-MS, high-resolution inductively coupled plasma-mass spectrometry; AAS,
atomic absorption spectrometry; GFAS, graphite furnace absorption spectroscopy. 63.5 µg/l is 1 µM.
Table 1. Normal/Control CSF concentrations of Cu in humans
[Cu] Method Reference
10.2 ug/L ICP-MS (Hozumi et al., 2011)
8.67 ug/L HR-ICP-MS (Melo et al., 2003)
9.10 ug/L AAS (Melo et al., 2003)
22.3 ug/L HR-ICP-MS (Gellein et al., 2007)
40.20 ug/L GFAS (Kapaki et al., 1989)
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Table 2
Concentration of Cu in adult brain
Data from whole brain and the indicated regions are summarized. 63.5 µg/gm wet weight is 1 µM.
Table 2. Normal/Control total brain concentrations of Cu in adult mammals by species
[Cu] Region Species Method Reference
~15 µg/g wet weight tissue Cerebral Cortex Mouse GFAS (Yang et al., 1998)
~50 µg/g wet weight tissue Hippocampus Mouse GFAS (Yang et al., 1998)
~72 µg/g wet weight tissue Cerebellum Mouse GFAS (Yang et al., 1998)
~14 µg/g wet weight tissue Brain stem Mouse GFAS (Yang et al., 1998)
12.7 µg/g dry weight tissue Cerebral Cortex Mouse AAS (White et al., 1999)
16.4 µg/g dry weight tissue Cerebellum Mouse AAS (White et al., 1999)
5.45 µg/g wet weight tissue Whole Brain Mouse ICP-MS (Waggoner et al., 2000)
2.8–10.3 µg/g wet weight tissue Hippocampus Mouse (30 BXD
strains)
ICP-MS (Jones et al., 2008)
2.0 µg/g wet weight tissue Whole Brain Rat FAAS (Critchfield et al., 1993)
~5–14 µg/g dry weight tissue 7 Regions across 3 ages Rat (LEA) ICP-MS (Saito et al., 1995)
2.79 µg/g wet weight tissue Average of 18 regions
(across 9 points of
development)
Rat ICP-MS (Tarohda et al., 2004)
~14 (8.74–17.07) µg/g Average of 8 regions Lamb STAT-AAS (Bakirdere et al., 2010)
3.75 (2.64–5.74) µg/g wet weight tissue Frontal Lobe Human ICP-AES (Rahil-Khazen et al., 2002)
5.83 (3.46–8.37) µg/g wet weight tissue Cerebellum Human ICP-AES (Rahil-Khazen et al., 2002)
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